Vir Biotechnology (VIR) Research & Development (2018 - 2026)

Vir Biotechnology has disclosed Research & Development across 9 years of filings, most recently posting $108.9 million for Q1 2026.

• Research & Development for Q1 2026 came in at $108.9 million, down 8.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $446.2 million (down 15.0% YoY), and the FY2025 annual result was $456.0 million, down 9.98% from the prior year.
• Research & Development came in at $108.9 million for Q1 2026 at Vir Biotechnology, up from $88.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $195.2 million in Q3 2024 to a low of $88.3 million in Q4 2025.
• The 5-year median for Research & Development is $114.2 million (2022), against an average of $125.0 million.
• Across the five-year window, Research & Development surged 74.72% in 2023 and sank 37.46% in 2024, its largest moves.
• Vir Biotechnology's Research & Development stood at $155.2 million in 2022, then slipped by 29.78% to $109.0 million in 2023, then fell by 2.65% to $106.1 million in 2024, then retreated by 16.72% to $88.3 million in 2025, then increased by 23.29% to $108.9 million in 2026.
• The last three Research & Development figures came in at $108.9 million (Q1 2026), $88.3 million (Q4 2025), and $151.5 million (Q3 2025), per Business Quant data.